1-11 of 11
Giovanni Paganelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia and Second Malignancy Following Yttrium-90 Ibritumomab Tiuxetan: 10-Year Single-Institution Experience of 138 Consecutive Patients

Anna Vanazzi, Chiara Grana, Daniele Laszlo, Marco Chinol, Mara Negri, Liliana Calabrese, Giovanni Paganelli, Giovanni Martinelli
Journal: Blood
Blood (2012) 120 (21): 4876.
https://doi.org/10.1182/blood.V120.21.4876.4876
Published: 2012
Journal Articles

Efficacy of 90 yttrium-Ibritumomab Tiuxetan in Extranodal Marginal-Zone Lymphoma,

Anna Vanazzi, Chiara Grana, Cristiano Crosta, Giancarlo Pruneri, Stefania Rizzo, Davide Radice, Antonello Pinto, Liliana Calabrese, Mara Negri, Giovanni Paganelli, Giovanni Martinelli, MD
Journal: Blood
Blood (2011) 118 (21): 3713.
https://doi.org/10.1182/blood.V118.21.3713.3713
Published: 2011
Journal Articles

Expression of the oncofetal ED-B–containing fibronectin isoform in hematologic tumors enables ED-B–targeted 131 I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

Stefanie Sauer, Paola A. Erba, Mario Petrini, Andreas Menrad, Leonardo Giovannoni, Chiara Grana, Burkhard Hirsch, Luciano Zardi, Giovanni Paganelli, Giuliano Mariani, Dario Neri, Horst Dürkop, Hans D. Menssen
Journal: Blood
Blood (2009) 113 (10): 2265–2274.
https://doi.org/10.1182/blood-2008-06-160416
Published: 2009
Journal Articles

Efficacy of 90 Y - Ibritumomab Tiuxetan in Relapsed or Refractory Primary Gastric Non Hodgkin Lymphoma

Anna Vanazzi, Pier Francesco Ferrucci, Chiara Maria Grana, Giancarlo Pruneri, Cristiano Crosta, Antonello Pinto, Marco Chinol, Liliana Calabrese, Giovanni Paganelli, Giovanni Martinelli
Journal: Blood
Blood (2008) 112 (11): 3063.
https://doi.org/10.1182/blood.V112.11.3063.3063
Published: 2008
Journal Articles

Red Marrow Dosimetry and Stem Cell Reinfusion in High Dose 90 Y - Ibritumomab Tiuxetan.

Anna Vanazzi, Daniele Laszlo, Marta Cremonesi, Chiara Maria Grana, Stefano Papi, Alessandra Alietti, Sarah Jayne Liptrott, Liliana Calabrese, Giovanni Paganelli, Giovanni Martinelli
Journal: Blood
Blood (2008) 112 (11): 2187.
https://doi.org/10.1182/blood.V112.11.2187.2187
Published: 2008
Journal Articles

High Dose 90Yttrium Ibritumomab Tiuxetan with PBSC Support in Refractory-Resistant NHL Patients.

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Marta Cremonesi, MPh, Margherita Clerici, RN, Davide Radice, ST, Stefano Papi, PhD, Liliana Calabrese, DM, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 1890.
https://doi.org/10.1182/blood.V110.11.1890.1890
Published: 2007
Journal Articles

Efficacy of 90Y-Ibritumomab Tiuxetan in Marginal-Zone Lymphoma (MZL).

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Giancarlo Pruneri, MD, Cristiano Crosta, MD, Antonello Pinto, MD, Marco Chinol, PhD, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2007) 110 (11): 4499.
https://doi.org/10.1182/blood.V110.11.4499.4499
Published: 2007
Journal Articles

Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation

Clinical Trials & Observations
Franck Morschhauser, Tim Illidge, Damien Huglo, Giovanni Martinelli, Giovanni Paganelli, Pier Luigi Zinzani, Simon Rule, Anna Marina Liberati, Noel Milpied, Georg Hess, Harald Stein, Joachim Kalmus, Robert Marcus
Journal: Blood
Blood (2007) 110 (1): 54–58.
https://doi.org/10.1182/blood-2007-01-068056
Published: 2007
Journal Articles

High Dose 90 Yttrium Ibritumomab Tiuxetan (Zevalin) with PBSC Support in Refractory-Resistant NHL Patients: A Phase I/II Study.

Anna Vanazzi, MD, Pier Francesco Ferrucci, MD, Chiara Grana, MD, Marta Cremonesi, MPH, Margherita Clerici, RN, Davide Radice, ST, STefano Papi, Liliana Calabrese, DM, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2006) 108 (11): 2720.
https://doi.org/10.1182/blood.V108.11.2720.2720
Published: 2006
Journal Articles

Efficacy of 90 Y-Ibritumomab Tiuxetan (Zevalin) in Refractory or Relapsed MALT Gastric Non Hodgkin’s Lymphoma.

Anna Vanazzi, MD, Pier F. Ferrucci, MD, Chiara Grana, MD, Giancarlo Pruneri, MD, Cristiano Crosta, MD, Antonello Pinto, MD, Marco Chinol, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2006) 108 (11): 2771.
https://doi.org/10.1182/blood.V108.11.2771.2771
Published: 2006
Journal Articles

High Dose Zevalin (90Yttrium Ibritumomab Tiuxetan) Treatment with PBSC Support in Refractory-Resistant NHL Patients: Preliminary Results of a Phase I/II Study.

Anna Vanazzi, MD, Pierfrancesco Ferrucci, MD, Mahila Ferrari, Liliana Calabrese, Marta Cremonesi, Mirco Bartolomei, MD, Giovanni Paganelli, MD, Giovanni Martinelli, MD
Journal: Blood
Blood (2005) 106 (11): 488.
https://doi.org/10.1182/blood.V106.11.488.488
Published: 2005